Pharmafile Logo
Pharmafocus logo
Advanced Search
akabia_logo

Akebia passes vadadustat for anaemia phase III study with FDA & EMA

October 7, 2015
Research and Development Akabia, FDA, anaemia

Akebia Therapeutics has announced the successful completion of the End-of-Phase II Meeting process with the FDA and the Scientific Advice …

News
joachim_hoeltz

Rondo AG appoints Joachim Hoeltz as chief exec

October 7, 2015
Manufacturing and Production, Research and Development, Sales and Marketing

Joachim Hoeltz has been appointed chief executive at pharmaceutical packaging company Rondo AG within the Business Area Medipak Systems. He …

Appointment
merckincweb

NICE approves Merck’s Keytruda for advanced skin cancer following ipilimumab treatment

October 7, 2015
Research and Development Merck, NHS, NICE, keytruda, skin cancer

The National Institute for Health and Care Excellence (NICE) has approved Merck’s Keytruda (pembrolizumab) for treating advanced skin cancer after …

News
aubagio

Sanofi MS treatment Aubagio slows brain atrophy in Phase III trial

October 7, 2015
Research and Development Genzyme, MS, Sanofi

Sanofi and its subsidiary Genzyme have announced that magnetic resonance imaging (MRI) data from the Phase III TEMSO study demonstrate …

News
aristada

FDA approves Alkermes schizophrenia treatment

October 6, 2015
Research and Development Alkermes, Aristada, FDA, schizophrenia

The US Food and Drug Administration (FDA) has approved Alkermes’s Aristada (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizophrenia. Aristada …

News
flu_vaccien_smaller

Flu jab reduces risk of stroke for two months

October 6, 2015
Research and Development flu vaccine, stroke

The risk of suffering a stroke is significantly reduced for up to two months after receiving a flu vaccine, a …

News
oral_insulin

Moving forward in diabetes

October 6, 2015
Research and Development Novo Nordiak, diabetes

As many as 387 million people worldwide are living with diabetes, and it is predicted that by 2035 more than …

Feature
diabetes_uk_logo

Novo Nordisk and Diabetes UK extend ‘Clinical Champions’ initiative

October 6, 2015
Medical Communications Novo Nordisk, diabetes

Diabetes UK and Novo Nordisk have announced the appointment of 20 Diabetes UK ‘Clinical Champions’, who will be supported and …

News
david-luther

David Luther joins MISSION Therapeutics

October 6, 2015
Manufacturing and Production, Medical Communications, Sales and Marketing

Cambridge, UK-based MISSION Therapeutics has announced the appointment of David Luther as chief financial officer.Luther brings more than 25 years’ …

Appointment
sodium_chloride

Baxter recalls saline after mould contamination

October 6, 2015
Manufacturing and Production baxter

Following a number of recalls earlier this year, Baxter has recalled potentially a further 140,000 bags of sodium chloride due …

News
palliative_care_rankings

UK tops Quality of Death rankings

October 6, 2015
Medical Communications NHS, ageing population, palliative care

The UK has ranked first in the 2015 Quality of Death Index, a measure of the quality of palliative care …

News
cardinal_health

Cardinal Health completes $1.944bn acquisition of J&J’s Cordis

October 6, 2015
Manufacturing and Production, Sales and Marketing Cardinal Health, Cordis, mergers and acquisitions

Cardinal Health has completed the acquisition of Johnson & Johnson’s Cordis business: a global leader in cardiology and endovascular devices, …

News
Pfizer HQ

Pfizer axes lay-off plans and creates new jobs

October 6, 2015
Manufacturing and Production Pfizer

A Pfizer facility in Ireland that was set to close has now been taken off the list of facilities no longer needed …

News
prof_colin_raston

Desktop device synthesising lidocaine could revolutionise pharma manufacturing

October 6, 2015
Manufacturing and Production lidocaine

A novel device with the ability to produce one of the most in-demand anaesthetics in any location may set the …

News
turing_logo

After Daraprim, Turing Pharma submits first in-house candidate to FDA

October 6, 2015
Manufacturing and Production, Research and Development turing

Turing Pharma may have been on the end of some less-than-favourable media coverage in recent weeks, but the company is …

News
teva

Teva acquires Mexico’s Rimsa for $2.3 billion

October 5, 2015
Research and Development, Sales and Marketing Mexico, Rimsa, Teva, mergers and acquisitions

Strategic Move Enhances Teva’s Presence in Mexico, the Second Largest Market in Latin America and a Major Emerging Market Brings a Portfolio of …

News

North 51 acquired by Bionical

October 5, 2015
Bionical, North 51, mergers and acquisitions

North 51 Ltd, a Nottingham-based healthcare company has been acquired by Bionical in a multi-million pound deal. The North 51 …

News
Press release
medcity_bojo

Why London is at the heart of life sciences

October 5, 2015
Research and Development NHS

by Eliot ForsterWhatever disease you’re trying to cure, you can bet that somebody in London has it. That probably isn’t …

Feature
keytruda

FDA approves Merck’s Keytruda for advanced NSC lung cancer

October 5, 2015
Research and Development, Sales and Marketing BMS, NSCL, keytruda, lung cancer, merck sharp and dohme, opdivo

The US Food and Drug Administration has granted accelerated approval for Merck’s Keytruda (pembrolizumab) to treat patients with advanced (metastatic) …

News
pfizer_hq_new_york

Pfizer completes $130 million purchase of two GSK vaccines

October 5, 2015
Sales and Marketing GSK, Pfizer, meningitis

Pfizer has announced that it has completed the $130 million acquisition of GlaxoSmithKline’s quadrivalent meningococcal ACWY vaccines Nimenrix and Mencevax. …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026